NEW YORK (GenomeWeb News) – Response Biomedical said today that as a result of the termination of a collaboration with 3M and 3M Innovative Properties, it has regained the worldwide rights to Flu A+B and respiratory syncytial virus products.
NEW YORK (GenomeWeb News) – CLC bio has been awarded a $2 million grant from the European Union to develop a software platform to support a multi-partner project using next-generation sequencing to identify infections, the company said today.
NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has been awarded two grants totaling €3 million ($3.6 million) to provide genomic analysis and commercialization services for two international studies.
NEW YORK (GenomeWeb) – In a long-awaited study appearing online today in Science, an Erasmus Medical Center-led team provide results from their study looking at the "bird flu," or avian H5N1 influenza A, virus' ability to morph into a form that is
NEW YORK (GenomeWeb News) – Cepheid today announced the US Food and Drug Administration has cleared the GeneXpert Infinity-80 System in conjunction with its Xpert Flu test.
Health management-services and diagnostics firm Alere is developing a pair of nucleic acid testing platforms, representing the company's first major move into the molecular diagnostics space, according to recent company presentations.
